Mirae Asset Global Investments Co., Ltd. Pliant Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,371 shares of PLRX stock, worth $3,603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,371
Previous 2,036
16.45%
Holding current value
$3,603
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PLRX
# of Institutions
155Shares Held
62.1MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$9.12 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.4MShares$8.21 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.56 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$5.07 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$4.64 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $74M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...